BioSpace News Archive

New research from Duke University, published in the March 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network, provides evidence that genomic recurrence score (RS) testing using the 21-gene assay is associated with decreased cancer care costs in real-world practice among certain patients with breast cancer who would otherwise receive standard chemotherapy.

Green Analytics Solidifies Presence with East Coast Testing Lab License

The Washington Mesothelioma Victims Center does not want one person in the State of Washington with recently diagnosed mesothelioma or asbestos exposure lung cancer to take their financial compensation for granted.

Patients who are currently enrolled in studies and receiving benefit from the therapy may continue with treatment, after consultation with their physician.

New study shows algae beta-glucan ingredient supports immune health

Lupus Research Alliance celebrates its 15th Annual Advocate for Lupus Research Day on Capitol Hill, sounding the need for increased federal funding to further advance new lupus treatments and the search for a cure.

The Genio® system is the world’s first and only battery-free, leadless and minimally invasive neurostimulator, capable of delivering bilateral hypoglossal nerve stimulation for moderate to severe OSA patients who have failed conventional Positive Airway Pressure (PAP) therapy.

The Marwood Group will present the keynote lunch address on Tuesday, while Wednesday’s keynote lunch speaker will be Dr. Jason Luke from the University of Chicago, who will address how to spot red flags in early clinical trials.

Boston Harbor Hotel, Boston, MA, June 5-6, 2019

At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart.